Have any questions?
+1-862-686-3898
CAS No.: 1431697-90-3
Inquire SB-408124 Hydrochloride (cas: 1431697-90-3 ) online by filling out the inquiry form, we will get back to you within 24 hours!
Product Details | |
---|---|
For research use only. Not Intended for Therapeutic Use! |
|
Cat No: | I001664 |
Synonyms: | (Z)-N/’-(6,8-difluoro-2-methylquinolin-4-yl)-N-(4-(dimethylamino)phenyl)carbamimidic acid hydrochloride |
Molecular Formula: | C19H19ClF2N4O |
Molecular Weight: | 392.835 |
IC50:: | 57 nM(Ki) |
Description: | SB408124 Hcl is a non-peptide antagonist for OX1 receptor with Ki of 57 nM and 27 nM in both whole cell and membrane, respectively; exhibits 50-fold selectivity over OX2 receptor.IC50 Value: 57 nM(Ki)Target: OX1 Receptorin vitro: SB-408124 binds hypocretin type 1 receptor (HcrtR1) with pKi values of 7.57. |
Price: | Get quote |
We would like to match the lowest price on market if possible.
SB408124 Hcl is a non-peptide antagonist for OX1 receptor with Ki of 57 nM and 27 nM in both whole cell and membrane, respectively; exhibits 50-fold selectivity over OX2 receptor.
IC50 Value: 57 nM(Ki)
Target: OX1 Receptor
in vitro: SB-408124 binds hypocretin type 1 receptor (HcrtR1) with pKi values of 7.57. Calcium mobilization studies shows that SB-408124 is a functional antagonist of the OX1 receptor with a affinity of approximately 50-fold selectivity over the OX2 receptor. A recent study indicates that pretreatment of primary cultures of rat astrocytes with SB-401824 before Orexin A administration significantly reduced the stimulatory action of Orexin A on both basal and forskolin-acivated cAMP production.
in vivo: SB-408124 (30 μg/10 μL, administered intracerebroventricularly) decreases Orexin-A induced water intake in Wistar rats. Intracerebroventricularly administered Orexin-A (30 μg/10 μL) blocks the vasopressin (VP) level increase induced by either histamine or 2.5% NaCl administration, and this blocking effect is moderated by pretreatment with SB-408124. Intracerebroventricular pretreatment with SB-408124 (50 mM, 5 μL/h) prevents Bicuculline (BIC)-induced increases in endogenous glucose production (EGP).
Your information is safe with us.